K-24

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameK-24

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionAngiotensin-converting enzyme inhibitors

TargetsAngiotensin-converting enzyme

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKyowa Hakko

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKyowa Hakko

Active IndicationsN/A

Inactive IndicationsHeart Failure

ATC CodeN/A